CellaVision And 2 Other Swedish Stocks Estimated To Be Trading Below Fair Value
In This Article:
As European inflation nears the central bank's target, the pan-European STOXX Europe 600 Index has reached record highs, suggesting a favorable environment for value investors. In this context, identifying undervalued stocks becomes crucial for those looking to capitalize on market inefficiencies.
Top 10 Undervalued Stocks Based On Cash Flows In Sweden
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| Sleep Cycle (OM:SLEEP) | SEK41.70 | SEK80.21 | 48% |
| CTT Systems (OM:CTT) | SEK273.00 | SEK499.55 | 45.4% |
| QleanAir (OM:QAIR) | SEK26.60 | SEK51.33 | 48.2% |
| Concentric (OM:COIC) | SEK226.50 | SEK411.51 | 45% |
| Dometic Group (OM:DOM) | SEK65.40 | SEK130.38 | 49.8% |
| Nolato (OM:NOLA B) | SEK55.00 | SEK99.23 | 44.6% |
| Mentice (OM:MNTC) | SEK26.10 | SEK50.98 | 48.8% |
| Svedbergs Group (OM:SVED BTA B) | SEK36.30 | SEK65.51 | 44.6% |
| BHG Group (OM:BHG) | SEK14.75 | SEK27.09 | 45.5% |
| MilDef Group (OM:MILDEF) | SEK82.60 | SEK162.75 | 49.2% |
Underneath we present a selection of stocks filtered out by our screen.
CellaVision
Overview: CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally, with a market cap of SEK6.32 billion.
Operations: CellaVision's revenue from automated microscopy systems and reagents in the field of hematology amounts to SEK726.40 million.
Estimated Discount To Fair Value: 27.1%
CellaVision is trading at SEK265, 27.1% below its fair value estimate of SEK363.44, and shows significant earnings growth potential with a forecasted annual increase of 24.09%. Recent earnings reports indicate strong performance, with Q2 sales rising to SEK187.79 million from SEK169.67 million a year ago and net income increasing to SEK38.55 million from SEK34.71 million. Revenue growth is expected at 13.6% per year, outpacing the Swedish market's 0.9%.
-
Navigate through the intricacies of CellaVision with our comprehensive financial health report here.
Thule Group
Overview: Thule Group AB (publ) is a sports and outdoor company based in Sweden with international operations, and it has a market cap of SEK32.25 billion.
Operations: Thule Group generates revenue primarily from its Outdoor & Bags segment, which accounts for SEK9.40 billion.
Estimated Discount To Fair Value: 10.7%
Thule Group is trading at SEK305, approximately 10.7% below its fair value estimate of SEK341.55. Recent earnings reports show solid performance, with Q2 sales rising to SEK3.1 billion from SEK3 billion a year ago and net income increasing to SEK559 million from SEK539 million. Thule's earnings are forecasted to grow at 15% annually, outpacing the Swedish market’s 14.9%, while revenue growth is expected at 6.1% per year.